VICI VENOUS STENT(R) System Demonstrates Positive Clinical Outcomes in Patients with Deep Venous Blockages
Results from the VIRTUS Study Show Venous Stent Met Its Primary Effectiveness and Safety Endpoints in Re-establishing Blood Flow at Twelve Months LEIPZIG, Germany and MARLBOROUGH, Mass., Jan. 22, 2019 -- (Healthcare Sales & Marketing Network) -- Today,... Devices, Interventional Boston Scientific, VICI VENOUS STENT, VIRTUS trial (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2019 Category: Pharmaceuticals Source Type: news

World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments
Siteman Cancer Center Advances Precision Cancer Care through Presentations, Peer-Reviewed Publications and Pioneering Clinical Experience on its MRIdian Systems CLEVELAND, Jan. 22, 2019 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2019 Category: Pharmaceuticals Source Type: news

Medline Awarded Laboratory Distribution Agreement with Intalere
NORTHFIELD, Ill., Jan. 21, 2019 -- (Healthcare Sales & Marketing Network) -- Medline, a global manufacturer and distributor of medical and laboratory products with patient-centered solutions, services and expertise across the continuum of care, today anno... Diagnostics, Distribution Medline, Intalere (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2019 Category: Pharmaceuticals Source Type: news

Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
With approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation ABBOTT PARK, Ill., Jan. 21, 2019 -- (Healt... Devices, Interventional, Cardiology, FDA Abbott, TactiCath, Ablation Catheter, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2019 Category: Pharmaceuticals Source Type: news

Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore
PALO ALTO, Calif. and SINGAPORE, Jan. 21, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced the installation of the gantry for the Varian ProBeam® Compact single-room proton therapy system at the new oncology center ... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2019 Category: Pharmaceuticals Source Type: news

Optimum Imaging Diagnostics (OIDx) is Proud to Announce the Release of Their First Commercial Test, the Histoplasma Capsulatum Urinary Antigen EIA Test
SCARBOROUGH, Maine, Jan. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum (1). Histoplasma capsulatum is a global concern and endemic to parts of Lat... Diagnostics, Product Launch Optimum Imaging Diagnostics, histoplasmosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2019 Category: Pharmaceuticals Source Type: news

Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Study did not meet the primary endpoints of overall survival (OS) in the full study population or in the leiomyosarcoma (LMS) sub-population; there was no difference in survival between the study arms for either population. There were no new safety sign... Biopharmaceuticals, Oncology Eli Lilly, LARTRUVO, olaratumab, soft tissue sarcoma, leiomyosarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2019 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Johnson & Johnson to collaborate with Apple to assess impact of wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes Up to 30 percent of AFib cases go undiagnosed until life-threatening complications occur, signaling... Devices, Cardiology, Monitoring Johnson & Johnson, Janssen Pharmaceuticals, Apple, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2019 Category: Pharmaceuticals Source Type: news

First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
PALO ALTO, Calif., Jan. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company's HyperArc™ High De... Devices, Oncology Varian Medical Systems, HyperArc, High Definition, Radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2019 Category: Pharmaceuticals Source Type: news

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures
Gantry breakthrough on industry-leading Azurion platform opens up new imaging and patient positioning opportunities to enhance care AMSTERDAM, Jan. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG, AEX: PHIA), a global lea... Devices, Radiology, Product Launch Royal Philips, Azurion, FlexArm, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2019 Category: Pharmaceuticals Source Type: news

Asceneuron Appoints Peter Van Vlasselaer as Chairman
Serial biotech entrepreneur joins leading small molecule tau modulation company LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 -- (Healthcare Sales & Marketing Network) -- Asceneuron, an emerging leader in the development of orally bioavail... Biopharmaceuticals, Neurology, Personnel Asceneuron, Progressive Supranuclear Palsy, tau pathology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2019 Category: Pharmaceuticals Source Type: news

Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox(R) Oxygenator
Innovative technology improves patient care during cardiopulmonary bypass ANN ARBOR, Mich., Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, today announced ... Devices, Surgery, Product Launch Terumo Cardiovascular, CAPIOX Oxygenator, NX19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2019 Category: Pharmaceuticals Source Type: news

Abbott To Acquire Cephea Valve Technologies, Inc.
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment ABBOTT PARK, Ill., Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) announced today... Devices, Interventional, Cardiology, Mergers & Acquisitions Abbott, Cephea Valve Technologies, Mitral valve, heart valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2019 Category: Pharmaceuticals Source Type: news

Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bowel Syndrome
Second Orphan Drug Designation for apraglutide, a next-generation, synthetic GLP-2 analog with a potentially best-in-class profile BASEL, Switzerland, Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Therachon AG ("Therachon"), a cl... Biopharmaceuticals, Gastroenterology, FDA Therachon, apraglutide, short bowel syndrome, achondroplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2019 Category: Pharmaceuticals Source Type: news

Lisa Genova, Ph.D joins CereVasc Board of Directors
BOSTON, Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- CereVasc, LLC, a company focused on improving the care of patients with communicating hydrocephalus announced today the addition of acclaimed neuroscientist and author Lisa Genova, Ph.D., ... Devices, Interventional, Neurology, Personnel CereVasc, eShunt, endovascular, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 16, 2019 Category: Pharmaceuticals Source Type: news

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement
All Patent Litigation Between the Companies to be Dismissed MARLBOROUGH, Mass. and IRVINE, Calif., Jan. 15, 2019 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) and Edwards Lifesciences Corporation (NYSE: EW) tod... Devices, Interventional, Cardiology, Litigation Boston Scientific, Edwards Lifesciences, transcatheter aortic valves (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2019 Category: Pharmaceuticals Source Type: news

CutisPharma Announces New Management Team Appointments
Mike Radice named as Chief Commercial Officer, current Chief Financial Officer Ron Scarboro will also assume role of Chief Operating Officer and Hanok George named as General Counsel WILMINGTON, Mass., Jan. 15, 2019 -- (Healthcare Sales & Marketing Netw... Biopharmaceuticals, Personnel CutisPharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2019 Category: Pharmaceuticals Source Type: news

ProKidney Announces $62 million Acquisition of inRegen
NEW YORK, Jan. 14, 2019 -- (Healthcare Sales & Marketing Network) -- ProKidney announces the acquisition of inRegen and its affiliate, Twin City Bio, LLC. ProKidney, LLC, was founded by a group of investors led by Pablo Legorreta, the Founder and CEO of ... Regenerative Medicine, Mergers & Acquisitions ProKidney, inRegen, kidney disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2019 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer
DESTINY-Breast04 to evaluate [fam-] trastuzumab deruxtecan (DS-8201) versus investigator's choice in HER2 low, unresectable and/or metastatic breast cancer previously treated with standard chemotherapy No anti-HER2 therapies are currently approved for H... Biopharmaceuticals, Oncology Daiichi Sankyo, trastuzumab, breast cancer, HER2 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2019 Category: Pharmaceuticals Source Type: news

SutroVax Announces Executive Appointments
Jane Wright-Mitchell appointed General Counsel Elaine Sun promoted to Chief Strategy Officer FOSTER CITY, Calif., Jan. 14, 2019 -- (Healthcare Sales & Marketing Network) -- SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-c... Biopharmaceuticals, Personnel SutroVax, conjugate vaccine, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2019 Category: Pharmaceuticals Source Type: news

INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility
MEDFORD, Mass., Jan. 14, 2019 -- (Healthcare Sales & Marketing Network) -- INVO Bioscience, Inc. (OTCQB: IVOB), developers of the INVOcell intravaginal culture (IVC) system, and Ferring Pharmaceuticals, a specialty biopharmaceutical group committed to hel... Biopharmaceuticals, Licensing INVO Bioscience, Ferring Pharmaceuticals, INVOcell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2019 Category: Pharmaceuticals Source Type: news

Amneal Announces Approval of Rivastigmine Transdermal System
BRIDGEWATER, N.J., Jan. 14, 2019 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received FDA approval for a generic version of Exelon® Patch (Rivastigmine Transdermal System), 4.6 m... Biopharmaceuticals, Drug Delivery, Generics, FDA Amneal Pharmaceuticals, Rivastigmine, Transdermal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2019 Category: Pharmaceuticals Source Type: news

Olympus Corporation Promotes U.S.-Based Company Leaders to Global Roles
Elevation of U.S.-based Executives Reflects International Nature of Business and Reinforces Olympus' Ongoing Transformation CENTER VALLEY, Pa., Jan. 11, 2019 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing ... Devices, Personnel Olympus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2019 Category: Pharmaceuticals Source Type: news

Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
NORTHBROOK, Ill., Jan. 10, 2019 -- (Healthcare Sales & Marketing Network) -- Astellas is pleased to announce three recent senior-level promotions and one new hire within its Medical and Development (M&D) organization. Erkut Bahceci, M.D., was promoted to ... Biopharmaceuticals, Personnel Astellas (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2019 Category: Pharmaceuticals Source Type: news

QT Ultrasound Opens Commercial Imaging Centers
Innovative New Trend in Breast Imaging is Now Available to the Public NOVATO, Calif., Jan. 10, 2019 -- (Healthcare Sales & Marketing Network) -- QT Ultrasound®, the developer of the FDA-cleared QTscan™ technology has announced the launch of commerc... Devices, Oncology, Product Launch QT Ultrasound, QTbreasthealth, breast ultrasound, ultrasound (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2019 Category: Pharmaceuticals Source Type: news

GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology
Dr. Stone will lead GigaGen's immuno-oncology research and discovery of first-in-class monoclonal antibody therapies SOUTH SAN FRANCISCO, Calif., Jan. 10, 2019 -- (Healthcare Sales & Marketing Network) -- GigaGen Inc., a biopharmaceutical company devel... Biopharmaceuticals, Oncology, Personnel GigaGen, immune dysregulation, immunotherapeutic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2019 Category: Pharmaceuticals Source Type: news

Net Health's Wound Care EHR, WoundExpert(R), Receives ONC-Health IT Certification
PITTSBURGH, Jan. 9, 2019 -- (Healthcare Sales & Marketing Network) -- Net Health, the leader in software solutions for specialized outpatient care, is pleased to announce that WoundExpert® version 7.0 has achieved Office of the National Coordinator fo... Devices, Wound Care Net Health, WoundExpert, wound care EHR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2019 Category: Pharmaceuticals Source Type: news

Leslie Kurtz Joins Jackson Healthcare as Chief Financial Officer
ATLANTA, Jan. 9, 2019 -- (Healthcare Sales & Marketing Network) -- Jackson Healthcare®, a family of highly-specialized healthcare, staffing and technology companies, today announced the appointment of Leslie Kurtz as Chief Financial Officer. In this r... Healthcare Recruiting, Personnel Jackson Healthcare (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2019 Category: Pharmaceuticals Source Type: news

NapaJen Pharma Closes $12.4 Million Series C Financing
TOKYO and BURLINGAME, Calif., Jan. 9, 2019 -- (Healthcare Sales & Marketing Network) -- NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel immunotherapeutic ... Biopharmaceuticals, Venture Capital NapaJen Pharma, immunotherapeutic, oligonucleotide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2019 Category: Pharmaceuticals Source Type: news

EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
EVENITY Approved to Reduce the Risk of Fractures and Increase Bone Mineral Density in Men and Postmenopausal Women With Osteoporosis at High Risk of Fracture EVENITY in Japan is Being Co-Developed Through a Strategic Alliance With Amgen Astellas BioPhar... Biopharmaceuticals, Regulatory Amgen, UCB, Astellas, EVENITY, romosozumab, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2019 Category: Pharmaceuticals Source Type: news

Cellenkos, Inc. Appoints Elizabeth Read as Chief Technology Officer, Adding Technology and Regulatory Affairs Expertise to its Executive Team
HOUSTON, Jan. 8, 2019 -- (Healthcare Sales & Marketing Network) -- Cellenkos® (Cellenkos), an early stage clinical biotechnology company developing umbilical cord blood-derived T-regulatory (Treg) cellular therapies for the treatment of autoimmune dis... Biopharmaceuticals, Personnel Cellenkos, cord blood, regulatory T cells, cellular therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2019 Category: Pharmaceuticals Source Type: news

Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer
CAMBRIDGE, Mass., Jan. 8, 2019 -- (Healthcare Sales & Marketing Network) -- Cygnal Therapeutics, a biotechnology company pioneering the field of exoneural biology for the treatment of cancer, autoimmune conditions, inflammation, and other diseases, today ... Biopharmaceuticals, Personnel Cygnal Therapeutics, exoneural biology, exoneural (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2019 Category: Pharmaceuticals Source Type: news

Protagonist Therapeutics Appoints Suneel K. Gupta, Ph.D., as Executive Vice President of Clinical Operations and Pharmacology
NEWARK, Calif., Jan. 7, 2019 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the appointment of Suneel Gupta, Ph.D., as Executive Vice President of Clinical Operations and Clinical Pharmacology. I... Biopharmaceuticals, Personnel Protagonist Therapeutics, hepcidin mimetic, anemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2019 Category: Pharmaceuticals Source Type: news

Lilly Announces Agreement To Acquire Loxo Oncology
Acquisition will broaden the scope of Lilly's oncology portfolio into precision medicines through the addition of a marketed therapy and a pipeline of highly selective potential medicines for patients with genomically defined cancers. Loxo Oncology's pi... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, Loxo Oncology, Vitrakvi, larotrectinib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2019 Category: Pharmaceuticals Source Type: news

Allevion Therapeutics Hires New CEO and Initiates Series A Funding
IRVINE, Calif., Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- Allevion Therapeutics announced today that the Board of Directors has appointed Troy Barring as the new CEO and Board Member of the company in preparation for Series A funding. Barr... Devices, Personnel Allevion Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical
LifeX CEO Dr. Dietrich Stephan to take over as NeuBase Therapeutics CEO; LifeX names University of Pittsburgh's Dr. Evan Facher as interim CEO PITTSBURGH, Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- LifeX™ today announced that its portfol... Biopharmaceuticals, Mergers & Acquisitions, Personnel NeuBase Therapeutics, Ohr Pharmaceutical, LifeX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
BRIDGEWATER, N.J., Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that it has appointed David A. Buchen to the newly expanded role of Senior Vice President, Chief Legal Officer and Cor... Biopharmaceuticals, Generics, Personnel Amneal Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer
Study to Explore Clinical Benefits of Precise, High Dose Radiation Therapy Enabled by MRIdian's MR-guidance Combined with Daily On-table Adaptation in Pancreatic Cancer CLEVELAND, Jan. 4, 2019 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. ... Devices, Oncology ViewRay, Stereotactic MRI-guided, On-table Adaptive Radiation Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
SAN FRANCISCO, January 4, 2019 -- (Healthcare Sales & Marketing Network) -- SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round ... Diagnostics, Venture Capital SOPHiA GENETICS, SOPHiA AI, Data-Driven Medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF Alpha Antibody Fragment
LAUSANNE, Switzerland, January 4, 2019 -- (Healthcare Sales & Marketing Network) -- Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments, has entered into an agreement to in license a novel topical... Biopharmaceuticals, Ophthalmology, Licensing Oculis , Novartis, Dry Eye Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million
New funds to expand portfolio and advance development of novel topical treatments for ophthalmic diseases LAUSANNE, Switzerland, January 4, 2019 -- (Healthcare Sales & Marketing Network) -- Oculis SA, a clinical-stage biopharmaceutical company developi... Biopharmaceuticals, Ophthalmology, Venture Capital Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Highly Complementary Portfolios with Leading Franchises in Oncology, Immunology and Inflammation and Cardiovascular Disease Significantly Expands Phase III Assets with Six Expected Near-Term Product Launches, Representing Greater Than $15 Billion in Rev... Biopharmaceuticals, Mergers & Acquisitions Bristol-Myers Squibb, Celgene (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2019 Category: Pharmaceuticals Source Type: news

Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Company Well-Positioned for Next Phase of Clinical Advancement with Lead Oral Drug Candidate, TG02, for Treatment of Adult and Pediatric Brain Cancers PRINCETON, N.J. and SAN DIEGO, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Tragara Phar... Biopharmaceuticals, Oncology, Personnel Adastra Pharmaceuticals, Tragara Pharmaceuticals, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2019 Category: Pharmaceuticals Source Type: news

Clinical Genomics Appoints Betsy Hanna CEO
Dr. Lawrence LaPointe Named Chief Innovation Officer BRIDGEWATER, N.J., Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the ap... Diagnostics, Oncology, Personnel Clinical Genomics, colorectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2019 Category: Pharmaceuticals Source Type: news

Roswell Biotechnologies Secures $32 Million Series A Financing Round
Harnessing the Power of Molecular Electronics to Revolutionize DNA Sequencing SAN DIEGO, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA... Diagnostics, Venture Capital Roswell Biotechnologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2019 Category: Pharmaceuticals Source Type: news

Dr. Jan M. Lundberg, Former Head of RandD at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors
Dr. Jan M Lundberg brings extensive industrial competence to Betagenon STOCKHOLM, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- "Jan's executive industrial experience as head of R&D at two major pharmaceutical companies, and his involv... Biopharmaceuticals, Personnel Betagenon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2019 Category: Pharmaceuticals Source Type: news

LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
SAN CLEMENTE, Calif., Jan. 2, 2019 -- (Healthcare Sales & Marketing Network) -- LIGHTMED Corporation, a global medical technology company, announced the reappointment of Founder and Executive Chairman Gary Lee as Chief Executive Officer, effective immedia... Devices, Ophthalmology, Dermatology, Personnel LIGHTMED, laser, cataract, glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news

Slayback Pharma announces FDA approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 mL in a multi-dose vial, the first generic equivalent of Makena(R) Injection 1,250 mg/ 5 mL multi-dose vial
PRINCETON, N.J., Jan. 2, 2019 -- (Healthcare Sales & Marketing Network) -- Slayback Pharma LLC announced today that the U.S. Food and Drug Administration ("FDA") granted approval of its abbreviated new drug application ("ANDA") for Hyd... Biopharmaceuticals, Generics, FDA Slayback Pharma, AMAG Pharmaceuticals, Makena (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news

Altavant Sciences Appoints Lyn Baranowski Chief Operating Officer
BASEL, Switzerland and DURHAM, N.C., Jan. 2, 2019 -- (Healthcare Sales & Marketing Network) -- Altavant Sciences, a company in the Roivant family focused on clinical development of novel therapies for pulmonary arterial hypertension and other indications,... Biopharmaceuticals, Personnel Altavant Sciences, rodatristat ethyl (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news

Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Mark H.N. Corrigan, MD to Succeed William Hunter, MD as Chief Executive Officer by the End of the First Quarter 2019 Dr. Hunter to Remain a Member of the Board of Directors Chief Financial Officer, Justin Renz, Appointed President Vanda De Cian, M... Biopharmaceuticals, Personnel Correvio Pharma, Xydalba, Zevtera, Mabelio, Brinavess (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news